Abstract
Online Supplementary Data. Table S1. Patient demographics and baseline characteristics, GOLDEN 2 (ITT population). Table S2. Patient demographics and baseline characteristics, GOLDEN 6 (safety population). Table S3. Change from baseline in trough FEV1 on Day 7 and Day 28, GOLDEN 2 (ITT population). Table S4. Change from baseline in trough FEV1 on Day 7, GOLDEN 6 (efficacy population). Table S5. Standardized change from baseline in FEV1AUC0–12 on Day 7 and Day 28, GOLDEN 2 (ITT population). Table S6. Standardized change from baseline in FEV1 AUC0–12 on Day 7, GOLDEN 6 (efficacy population). Table S7. Change from baseline in peak FEV1 on Day 28, GOLDEN 2 (ITT population). Figure S1. Least squares mean change from baseline in FEV1 over time on Day 28 (GOLDEN 2 Substudya ITT population). Figure S2. Mean change from baseline in FEV1 over time on Day 7 (GOLDEN 6 efficacy population). (DOCX 269 kb)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
